Brief: Instil Bio Presents Subset Analysis Of Patients With Advanced Melanoma At 2021 Esmo Congress
Brief: Instil Bio Gets Clearance For Phase 2 Trial For Patients With Advanced Melanoma
Instil Bio Inc reports results for the quarter ended in June - Earnings Summary
Brief: Instil Bio Reports Second Quarter 2021 Financial Results And Provides Corporate Update
Instil Bio Inc reports results for the quarter ended in March - Earnings Summary
Brief: Instil Bio Inc - Presented Clinical Data From A Compassionate Use Program For Treatment Of Metastatic Melanoma